Polar Capital Holdings PLC Arcutis Biotherapeutics, Inc. Transaction History

Polar Capital Holdings PLC

  • $16.3 Billion
  • Q3 2024

A detailed history of Polar Capital Holdings PLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 6,884,372 shares of ARQT stock, worth $97.1 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
6,884,372
Previous 6,879,072 0.08%
Holding current value
$97.1 Million
Previous $64 Million 0.08%
% of portfolio
0.39%
Previous 0.39%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$8.32 - $11.0 $44,096 - $58,300
5,300 Added 0.08%
6,884,372 $64 Million
Q2 2024

Aug 14, 2024
SELL
$7.24 - $12.53 $49,594 - $85,830
-6,850 Reduced 0.1%
6,879,072 $64 Million
Q1 2024

May 15, 2024
BUY
$3.25 - $11.77 $1.91 Million - $6.92 Million
588,234 Added 9.34%
6,885,922 $68.2 Million
Q4 2023

Feb 14, 2024
BUY
$1.84 - $4.82 $5.85 Million - $15.3 Million
3,179,744 Added 101.98%
6,297,688 $20.3 Million
Q3 2023

Nov 14, 2023
SELL
$5.31 - $10.98 $52,213 - $107,966
-9,833 Reduced 0.31%
3,117,944 $16.6 Million
Q2 2023

Dec 13, 2023
SELL
$7.51 - $15.0 $58,097 - $116,040
-7,736 Reduced 0.25%
3,127,777 $29.8 Million
Q2 2023

Aug 14, 2023
SELL
$7.51 - $15.0 $58,097 - $116,040
-7,736 Reduced 0.25%
3,127,777 $29.8 Million
Q1 2023

Dec 13, 2023
BUY
$10.23 - $17.14 $179,730 - $301,132
17,569 Added 0.56%
3,135,513 $34.5 Million
Q1 2023

May 15, 2023
BUY
$10.23 - $17.14 $11.6 Million - $19.4 Million
1,129,736 Added 56.32%
3,135,513 $34.5 Million
Q4 2022

Feb 14, 2023
BUY
$13.96 - $20.4 $9.72 Million - $14.2 Million
696,509 Added 53.2%
2,005,777 $29.7 Million
Q3 2022

Nov 14, 2022
SELL
$17.85 - $26.95 $1.72 Million - $2.6 Million
-96,528 Reduced 6.87%
1,309,268 $25 Million
Q2 2022

Aug 15, 2022
SELL
$16.33 - $22.2 $6.18 Million - $8.4 Million
-378,209 Reduced 21.2%
1,405,796 $30 Million
Q4 2021

Feb 14, 2022
BUY
$14.98 - $25.5 $3.52 Million - $6 Million
235,104 Added 15.18%
1,784,005 $37 Million
Q3 2021

Nov 15, 2021
SELL
$19.28 - $27.1 $2.58 Million - $3.62 Million
-133,642 Reduced 7.94%
1,548,901 $37 Million
Q2 2021

Aug 16, 2021
BUY
$24.42 - $34.75 $3.05 Million - $4.34 Million
125,000 Added 8.03%
1,682,543 $45.9 Million
Q1 2021

May 17, 2021
BUY
$24.47 - $36.98 $19.1 Million - $28.9 Million
782,543 Added 100.97%
1,557,543 $45.1 Million
Q4 2020

Feb 16, 2021
BUY
$17.82 - $31.73 $13.8 Million - $24.6 Million
775,000 New
775,000 $21.8 Million

Others Institutions Holding ARQT

# of Institutions
197
Shares Held
129M
Call Options Held
738K
Put Options Held
82K
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $849M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email